|
Volumn 27, Issue 2, 2000, Pages 177-186
|
Chemotherapy for renal cell carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
DOCETAXEL;
FLOXURIDINE;
FLUOROURACIL;
GAMMA INTERFERON;
INTERFERON;
INTERLEUKIN 2;
ISOTRETINOIN;
MITOXANTRONE;
MITOZOLOMIDE;
N METHYLFORMAMIDE;
NAVELBINE;
OXANTHRAZOLE;
PACLITAXEL;
PIPERAZINEDIONE;
PIRARUBICIN;
SPARFOSIC ACID;
SPIROGERMANIUM;
SULOFENUR;
SURAMIN;
TAUROMUSTINE;
TENIPOSIDE;
THIOTEPA;
TIOGUANINE;
TOPOTECAN;
TRIAZINATE;
TRIMETREXATE;
UNINDEXED DRUG;
VINBLASTINE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CONTINUOUS INFUSION;
DRUG INDUCED DISEASE;
HUMAN;
KIDNEY CARCINOMA;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
DRUG RESISTANCE, MULTIPLE;
DRUG THERAPY, COMBINATION;
HUMANS;
KIDNEY NEOPLASMS;
NEOPLASM METASTASIS;
|
EID: 0034038518
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (189)
|
References (212)
|